Fractures
|
Q1, Q2, Q3
|
Examination for osteoporosis
|
Q1, Q2, Q3
|
Hip fractures of close family
|
Q1, Q2, Q3
|
Falls in last 12 months
|
Q1, Q2, Q3
|
Fear of falling
|
Q1, Q2, Q3
|
Mobility and use of walking aid
|
Q1, Q2, Q3
|
Height and weight
|
Q1, Q2, Q3
|
Living situation
|
Q1, Q2, Q3
|
Education level
|
Q1
|
Ethnicity
|
Q1
|
Age of start menopause
|
Q1
|
Smoking and alcohol use
|
Q1, Q2, Q3
|
Use of dairy products
|
Q1, Q2, Q3
|
Use of vitamin D/ calcium/ multi-vitamin supplements
|
Q1, Q2, Q3
|
Medication use
|
Q1, Q2, Q3
|
Use of osteoporosis medication
|
Q1, Q2, Q3
|
Prednison use
|
Q1
|
Chronic diseases
|
Q1, Q2, Q3
|
Quality of life (EuroQoL-5D)
|
Q2, Q3
|
Consultation physician
|
Q2, Q3
|
Hospital admission
|
Q2, Q3
|
Dizziness
|
Q2
|
Incontinence
|
Q2
|
Memory complaints
|
Q2
|
Depression and anxiety (PHQ-4)
|
Q2
|
Attitude toward osteoporosis and perceived risks
|
Q2
|
Adherence and persistence to use osteoporosis medication (ADEOS-12)
|
Q2a
|
Side effects of osteoporosis medication
|
Q2a
|
Independence
|
Q3
|
Diabetes treatment
|
Q3b
|
Diabetes complications and hypoglycaemic attacks
|
Q3b
|
Sunlight exposure
|
QDc
|
Vitamin D via diet and supplements
|
QDc
|